Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.400

+0.060 (4.48%)

At close: Jun 18, 2026, 4:00 PM EDT

1.390

-0.010 (-0.71%)

After-hours: Jun 18, 2026, 7:52 PM EDT

PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	160.03	160.01	154.01	200.52	128.3	130.51
Revenue Growth (YoY)	5.04%	3.89%	-23.19%	56.29%	-1.69%	65.43%
Cost of Revenue	99.31	109.33	107.34	145.76	78.54	71.35
Gross Profit	60.72	50.67	46.68	54.76	49.77	59.17
Selling, General & Admin	132.48	141.49	175.02	169.82	160.85	124.12
Depreciation & Amortization Expenses	4.06	369.44	27.4	8.14	0.73	0.31
Research & Development	87.86	97.31	134.92	187.17	193	112.9
Other Operating Expenses	61.2	-3.7	183.65	24.1	2.38	32.27
Total Operating Expenses	285.6	604.54	520.99	389.23	356.96	269.6
Operating Income	-133.28	-553.86	-474.31	-334.47	-307.2	-210.44
Interest Expense	-6.96	-6.95	-13.41	-14.34	-14.69	-12.53
Other Non-Operating Income (Expense)	12.47	14.76	178.19	30.65	7.64	-51.91
Total Non-Operating Income (Expense)	5.51	7.8	164.78	16.31	-7.05	-64.44
Pretax Income	-127.77	-546.06	-309.54	-318.16	-314.25	-274.87
Provision for Income Taxes	0.8	0.32	0.32	-11.42	-	-93.65
Net Income	-128.58	-546.38	-309.85	-306.74	-314.25	-181.22
Net Income to Common	-128.58	-546.38	-309.85	-306.74	-314.25	-181.22
Shares Outstanding (Basic)	310	302	294	268	227	221
Shares Outstanding (Diluted)	310	302	294	268	227	221
Shares Change (YoY)	3.48%	2.56%	9.96%	18.21%	2.50%	14.92%
EPS (Basic)	-0.41	-1.81	-1.05	-1.15	-1.39	-0.82
EPS (Diluted)	-0.41	-1.81	-1.05	-1.15	-1.39	-0.82
Free Cash Flow	-116.21	-113.92	-212.25	-268.02	-279.96	-117.11
Free Cash Flow Per Share	-0.37	-0.38	-0.72	-1.00	-1.24	-0.53
Gross Margin	37.95%	31.67%	30.31%	27.31%	38.79%	45.33%
Operating Margin	-83.29%	-346.15%	-307.97%	-166.80%	-239.43%	-161.24%
Profit Margin	-80.34%	-341.47%	-201.18%	-152.97%	-244.93%	-138.85%
FCF Margin	-72.62%	-71.20%	-137.81%	-133.66%	-218.20%	-89.73%
EBITDA	-119.15	-171.43	-433.13	-314.74	-296.8	-202.86
EBITDA Margin	-74.45%	-107.14%	-281.23%	-156.96%	-231.33%	-155.43%
EBIT	-133.28	-553.86	-474.31	-334.47	-307.2	-210.44
EBIT Margin	-83.29%	-346.15%	-307.97%	-166.80%	-239.43%	-161.24%
Effective Tax Rate	-0.63%	-0.06%	-0.10%	3.59%	0.00%	34.07%

SEC Filings: 10-K · 10-Q